3-[5-(4-bromophenyl)imidazo[1,2-b]isoindol-5-yl]-1-[4-[(2-methyl-1,3-thiazol-4-yl)methyl]piperazin-1-yl]propan-1-one

C28H28BrN5OS — CID 58415440

IUPAC3-[5-(4-bromophenyl)imidazo[1,2-b]isoindol-5-yl]-1-[4-[(2-methyl-1,3-thiazol-4-yl)methyl]piperazin-1-yl]propan-1-one
SMILESCc1nc(CN2CCN(C(=O)CCC3(c4ccc(Br)cc4)c4ccccc4-c4nccn43)CC2)cs1
InChIInChI=1S/C28H28BrN5OS/c1-20-31-23(19-36-20)18-32-14-16-33(17-15-32)26(35)10-11-28(21-6-8-22(29)9-7-21)25-5-3-2-4-24(25)27-30-12-13-34(27)28/h2-9,12-13,19H,10-11,14-18H2,1H3
InChIKeyJOGYOLAWASIREH-UHFFFAOYSA-N
MW562.54 g/mol
LogP5.31
Rot. Bonds6

About 3-[5-(4-bromophenyl)imidazo[1,2-b]isoindol-5-yl]-1-[4-[(2-methyl-1,3-thiazol-4-yl)methyl]piperazin-1-yl]propan-1-one

3-[5-(4-bromophenyl)imidazo[1,2-b]isoindol-5-yl]-1-[4-[(2-methyl-1,3-thiazol-4-yl)methyl]piperazin-1-yl]propan-1-one (PubChem CID 58415440) has the molecular formula C28H28BrN5OS and a molecular weight of 562.54 g/mol. Its IUPAC name is 3-[5-(4-bromophenyl)imidazo[1,2-b]isoindol-5-yl]-1-[4-[(2-methyl-1,3-thiazol-4-yl)methyl]piperazin-1-yl]propan-1-one.

Molecular Properties

Compound Name3-[5-(4-bromophenyl)imidazo[1,2-b]isoindol-5-yl]-1-[4-[(2-methyl-1,3-thiazol-4-yl)methyl]piperazin-1-yl]propan-1-one
PubChem CID58415440
Molecular FormulaC28H28BrN5OS
Molecular Weight562.54 g/mol
Exact Mass561.12
IUPAC Name3-[5-(4-bromophenyl)imidazo[1,2-b]isoindol-5-yl]-1-[4-[(2-methyl-1,3-thiazol-4-yl)methyl]piperazin-1-yl]propan-1-one
SMILESCc1nc(CN2CCN(C(=O)CCC3(c4ccc(Br)cc4)c4ccccc4-c4nccn43)CC2)cs1
InChIInChI=1S/C28H28BrN5OS/c1-20-31-23(19-36-20)18-32-14-16-33(17-15-32)26(35)10-11-28(21-6-8-22(29)9-7-21)25-5-3-2-4-24(25)27-30-12-13-34(27)28/h2-9,12-13,19H,10-11,14-18H2,1H3
InChIKeyJOGYOLAWASIREH-UHFFFAOYSA-N
XLogP5.31
TPSA54.26 Ų
H-Bond Donors
H-Bond Acceptors6
Rotatable Bonds6
Heavy Atoms36
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500562.54
LogP ≤ 55.31
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 106

Analyze 3-[5-(4-bromophenyl)imidazo[1,2-b]isoindol-5-yl]-1-[4-[(2-methyl-1,3-thiazol-4-yl)methyl]piperazin-1-yl]propan-1-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 3-[5-(4-bromophenyl)imidazo[1,2-b]isoindol-5-yl]-1-[4-[(2-methyl-1,3-thiazol-4-yl)methyl]piperazin-1-yl]propan-1-one?
The IUPAC name of 3-[5-(4-bromophenyl)imidazo[1,2-b]isoindol-5-yl]-1-[4-[(2-methyl-1,3-thiazol-4-yl)methyl]piperazin-1-yl]propan-1-one (CID 58415440) is 3-[5-(4-bromophenyl)imidazo[1,2-b]isoindol-5-yl]-1-[4-[(2-methyl-1,3-thiazol-4-yl)methyl]piperazin-1-yl]propan-1-one.
What is the SMILES notation for 3-[5-(4-bromophenyl)imidazo[1,2-b]isoindol-5-yl]-1-[4-[(2-methyl-1,3-thiazol-4-yl)methyl]piperazin-1-yl]propan-1-one?
The canonical SMILES for 3-[5-(4-bromophenyl)imidazo[1,2-b]isoindol-5-yl]-1-[4-[(2-methyl-1,3-thiazol-4-yl)methyl]piperazin-1-yl]propan-1-one is Cc1nc(CN2CCN(C(=O)CCC3(c4ccc(Br)cc4)c4ccccc4-c4nccn43)CC2)cs1.
What is the InChIKey of 3-[5-(4-bromophenyl)imidazo[1,2-b]isoindol-5-yl]-1-[4-[(2-methyl-1,3-thiazol-4-yl)methyl]piperazin-1-yl]propan-1-one?
The InChIKey is JOGYOLAWASIREH-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H28BrN5OS/c1-20-31-23(19-36-20)18-32-14-16-33(17-15-32)26(35)10-11-28(21-6-8-22(29)9-7-21)25-5-3-2-4-24(25)27-30-12-13-34(27)28/h2-9,12-13,19H,10-11,14-18H2,1H3.
What are the key properties of 3-[5-(4-bromophenyl)imidazo[1,2-b]isoindol-5-yl]-1-[4-[(2-methyl-1,3-thiazol-4-yl)methyl]piperazin-1-yl]propan-1-one?
3-[5-(4-bromophenyl)imidazo[1,2-b]isoindol-5-yl]-1-[4-[(2-methyl-1,3-thiazol-4-yl)methyl]piperazin-1-yl]propan-1-one has a molecular weight of 562.54 g/mol, XLogP of 5.31, 6 rotatable bonds, 0 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[5-(4-bromophenyl)imidazo[1,2-b]isoindol-5-yl]-1-[4-[(2-methyl-1,3-thiazol-4-yl)methyl]piperazin-1-yl]propan-1-one is sourced from PubChem (CID 58415440), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).